Bone Cancer

Treatment Of Bone Cancer

FST is an educational resource. If you would like further information on chemotherapies used in cancer treatment, please visit the British National Formulary (BNF)://bnf.nice.org.uk/

Supporting Images

NCCN guidelines: Bone Cancer
Ewing Sarcoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bone Cancer, Version 2.2025.
OSTEO 1: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bone Cancer, Version 2.2025.
OSTEO 2: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bone Cancer, Version 2.2025.
OSTEO 3: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bone Cancer, Version 2.2025.
OSTEO 4: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bone Cancer, Version 2.2025.

Challenges in Bone Cancer Treatment

The two main challenges are:
Repairing large bone defects
Eradicating any remaining tumour cells.

Outcomes have not significantly improved for osteosarcoma and Ewing sarcoma, and therefore, there is a need to find better treatments and overcome conventional treatments (surgery, chemotherapy, and radiotherapy.

Follow Up Appointments

Goals of follow-up appointments

To monitor progress and coping with health issues.

To manage long-term toxicity of chemotherapy and radiotherapy.

To manage complications of surgery, e.g. reconstruction

To minimise risks:

There are rare cases of secondary leukaemia, e.g. acute myeloid leukaemia after 2 to 5 years of chemotherapy.

Other risks are germline cancer predisposition syndrome; this can be detected from molecular techniques like whole-genome sequencing (WGS)

Local recurrences are often detectable by patients.

How are these goals achieved?

To perform physical examination of the primary tumours

To conduct periodic cross-sectional imaging to monitor recurrence or metastasis, especially in lungs/lymph nodes. This could be head-to-toe FDG-PET, CT, and/or bone scan.

To perform functional assessment at every visit.

To conduct full blood cell count and other laboratory tests

To follow cancer surveillance programmes especially patients with osteosarcoma and Li-Fraumeni syndrome.

Follow-up Timelines in Accordance with NCCN Guidelines

Generally

Low grade bone sarcoma

Late metastasis, local recurrences and failure of reconstruction

It may occur for more than ten years post-diagnosis in all tumours. There is no fixed stopping point for follow-up.

Chest Surveillance

Returning chordoma (occult local recurrence)

Chordoma is a rare bone cancer that arises in the notochord area beneath the neural tube in the embryological origin. It is a type of mesodermal tissue.

A patient had a recurrence of cancer after the removal of pelvic chondrosarcoma

It is detected by X-rays, the key steps are as follows:

Regular MRI of primary site.

Recommended Reading

References

Bădilă, A.E., Rădulescu, D.M., Niculescu, A.-G., Grumezescu, A.M., Rădulescu, M. and Rădulescu, A.R. (2021). Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review. Cancers, [online] 13(16), p.4229. doi:https://doi.org/10.3390/cancers13164229.

Biology Insights (2025) What Is Coralline Algae and Why Is It Important? Available at: https://biologyinsights.com/what-is-coralline-algae-and-why-is-it-important-2/ (Accessed: 11th June 2026)

Bone Cancer Research Trust (2026) Giant Cell Tumour of the Bone Available at:https://www.bcrt.org.uk/information/information-by-type/giant-cell-tumor/  (Accessed: 4th April 2026)

Budhu, J.A., Wen, P.Y. and Lee, E.Q. (2022). Neurologic complications of oncologic therapy. Handbook of Neuro-Oncology Neuroimaging, pp.131–155. doi:https://doi.org/10.1016/b978-0-12-822835-7.00013-5.

Cancer Research UK (2026) Mifamurtide (Mepact). Available at: https://www.cancerresearchuk.org/about-cancer/treatment/drugs/mifamurtide (Accessed: 11th June 2026)

Cancer Research UK (n.d.) Radiotherapy for bone cancer. Available at: https://www.cancerresearchuk.org/about-cancer/bone-cancer/treatment/radiotherapy-treatment (Accessed: 5th June 2026)

Cleveland Clinic (2022) MUGA Scan. Available at: https://my.clevelandclinic.org/health/diagnostics/17247-multigated-acquisition-scan-muga (Accessed: 4th June 2026)

Gemcitabine (n.d.) Gemcitabine. Available at: https://www.cancerresearchuk.org/about-cancer/treatment/drugs/gemcitabine (Accessed: 9th June 2026)

Kager, L., Pötschger and Bielack (2010). Review of mifamurtide in the treatment of patients with osteosarcoma. Therapeutics and Clinical Risk Management, p.279. doi:https://doi.org/10.2147/tcrm.s5688.

Livestock conservancy (n.d) Animal Terms and Their Proper Usage. Available  at: https://livestockconservancy.org/resources/animal-terms/ (Accessed: 11th June 2026)

Marshall, E. (2026) Actions of Protein Kinases (PKs) Downstream of Akt. Available at: https://www.biorender.com/template/actions-of-protein-kinases-pks-downstream-of-akt (Accessed: 9th June 2026)

Najid, M.  (2025) Coagulation Necrosis: Definition, Histology, and Clinical Significance. Available at: https://cancerbiologyresearch.com/coagulation-necrosis-definition-histology-and-clinical-significance/ (Accessed: 9th June 2026)

National Cancer Institute (2019) Adamantinoma. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/adamantinoma (Accessed: 4th April 2026)

National Cancer Institute (2019) Monoclonal antibodies. Available at: https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies (Accessed: 9th June 2026)

National Health Service (2025) Treatment for bone cancer. Available at: https://www.nhs.uk/conditions/bone-cancer/treatment/ (Accessed: 4th April 2026)

National Institute for Health and Care Excellence (2026) Glucarpidase. Available at: https://bnf.nice.org.uk/drugs/glucarpidase/ (Accessed: 11th June 2026)

National Institute for Health and Care Excellence (2026) How dose carbozantinib work? Available at: https://www.cancerresearchuk.org/about-cancer/treatment/drugs/cabozantinib-tablets#how-does-cabozantinib-work (Accessed: 9th June 2026)

Pietrangelo, A. (2019) What is fibrosarcoma and how is it treated? Available at: https://www.healthline.com/health/fibrosarcoma (Accessed 3rd April 2026)

Pullan, J. and Lotfollahzadeh, S. (2024). Primary Bone Cancer. Available at: https://www.ncbi.nlm.nih.gov/books/NBK560830/ (Accessed: 9th April 2026)

Rajamani, K, V., Udayshankar, V., Prakash, P. and Jain, V. (2019). Bone graft materials used in dental implants: A review. IP Annals of Prosthodontics and Restorative Dentistry, 5(3), pp.58–62. doi:https://doi.org/10.18231/j.aprd.2019.014.

‌Takeuchi, A., Yamamoto, N., Hayashi, K., Matsubara, H., Miwa, S., Igarashi, K. and Tsuchiya, H. (2019). Joint-preservation surgery for pediatric osteosarcoma of the knee joint. Cancer and Metastasis Reviews, 38(4), pp.709–722.

doi:https://doi.org/10.1007/s10555-019-09835-z.

Thomas, A., Bates, S.M Figg, W. and Pommier, Y. (2017) DNA Topoisomerase-targeting drugs. Available at:  https://oncohemakey.com/dna-topoisomerase-targeting-drugs/ (Accessed: 9th June 2026)

Trusolino, L., Bertotti, A. and Comoglio, P.M. (2010). MET signalling: principles and functions in development, organ regeneration and cancer. Nature Reviews Molecular Cell Biology, 11(12), pp.834–848. doi:https://doi.org/10.1038/nrm3012.

Tumor Surgery (2026) Adamantinoma: A Rare Bone Tumor of the Tibia Explained. Available at: https://www.tumorsurgery.org/2025/12/16/adamantinoma-rare-bone-tumor-tibia/ (Accessed: 4th April 2026)

Vitality (2025) Mineralised vs demineralized bone grafts: which is better for implant success?  Available at: https://www.vitality-product.com/blogs/news/mineralized-vs-demineralized-bone-grafts-which-is-better-for-implant-success (Accessed: 4th June 2026)

Your Genome (n.d.) What is mitosis? Available at: https://www.yourgenome.org/theme/what-is-mitosis/ (Accessed: 4th June 2026)

Updated July 2026 Next Review July 2028

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14